Starpharma Holdings Limited
SPHRF
$0.084
$0.00020.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -60.81% | -7.04% | 125.08% | 120.20% | 116.96% |
| Total Other Revenue | -- | -- | -- | -91.85% | -87.26% |
| Total Revenue | -60.92% | -8.07% | 118.10% | 111.65% | 107.04% |
| Cost of Revenue | -15.93% | -15.27% | -15.80% | -16.79% | -17.01% |
| Gross Profit | -405.16% | 27.02% | 88.42% | 88.18% | 87.44% |
| SG&A Expenses | -8.80% | -7.50% | -7.52% | -6.37% | -4.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.18% | -12.29% | -12.64% | -12.96% | -12.54% |
| Operating Income | -46.16% | 14.90% | 48.99% | 49.37% | 49.08% |
| Income Before Tax | -46.16% | 14.90% | 48.99% | 49.37% | 49.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -46.16% | 14.90% | 48.99% | 49.37% | 49.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.16% | 14.90% | 48.99% | 49.37% | 49.08% |
| EBIT | -46.16% | 14.90% | 48.99% | 49.37% | 49.08% |
| EBITDA | -48.90% | 14.76% | 49.70% | 50.12% | 49.87% |
| EPS Basic | -45.26% | 15.82% | 49.42% | 49.81% | 49.63% |
| Normalized Basic EPS | -45.35% | 15.45% | 49.07% | 49.09% | 49.41% |
| EPS Diluted | -34.90% | 19.71% | 51.30% | 48.90% | 45.82% |
| Normalized Diluted EPS | -45.35% | 15.45% | 49.07% | 49.09% | 49.41% |
| Average Basic Shares Outstanding | 0.96% | 0.77% | 0.59% | 0.56% | 0.52% |
| Average Diluted Shares Outstanding | 0.96% | 0.77% | 0.59% | 0.56% | 0.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |